MMED MiniMed Group, Inc. Common Stock

XNAS 18.66 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MMED $18.66 —
Key stats
$18.66
Pre-market $18.88 +1.18%
52-Week Range
$10.65 – $24.43
YTD
+0.92%
IV Rank (30D)
18.17
Straddle Price
$2.25
P/C Vol Ratio
0.11
Market Cap
$5.2B
Open
$18.29
Day Range
$18.07 – $18.69
Volume
5,289,813
Prev Close
$18.34
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY0.61
Cost of Equity (CAPM)8.03% (VRP-adj)
WACC8.16%
Volatility Risk Premium+66.7pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Return on Equity (TTM)-8.9%
Book / Price98.6% — banking bias active (P/B is primary)
Gross Margin (TTM)53.7%
Debt / Equity0.00
Quality Score2/6 — normal (10y DCF)
SMA 50$20.23 (Market Anchor value)
SMA 20 / Bollinger Mid$18.75
Bollinger Width / SMA20109.6% (drives anchor stability)
Net Debt$-0.2B
Market Cap$4B
Peers used for multiples: ALGN, GMED, MDLN (filtered from 8 ETF-co-members; sector bias active)
Blended Fair Value
$46.00
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 26.5× · 3 peers
Peer EV/EBITDA n/a 0% median 11.4× · 3 peers
Peer P/B $47.68 50% median 2.6× · 3 peers
Peer P/S $44.32 50% median 2.6× · 3 peers
Market Anchor (SMA50) $20.23 0% stability 0% (BB-width)
Options Expected (B-L 30d) $18.44 0% 7 strikes · skew -0.72
As of 2026-10-27 · updated
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$5.2B
Employees
2,800
List Date
2026-03-06
CIK
0002062583
Headquarters
Northridge, CA
Homepage
https://www.minimed.com

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan----
Feb----
Mar-19.31%-19.31%
Apr-14.78%-14.78%
May-0.58%-0.58%
Jun24.58%24.58%
Jul17.36%17.36%
Aug6.07%6.07%
Sep-13.16%-13.16%
Oct-4.80%*-4.80%
Nov----
Dec----
Total-12.35%-12.35%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $18.75
SMA 50: $20.23
SMA 200: —
Current: $18.66
EMA 12: $18.38
EMA 26: $19.02
MACD: -0.6343 | Signal: 0.0466
BEARISH
ADX (14): 33.08
TREND
+DI: 11.69
−DI: 22.41

Momentum Oscillators

RSI (14): 46.83
NEUTRAL
Stoch %K: 52.07
Stoch %D: 44.07
Williams %R: -41.45

Volume & Volatility

BB Upper: $20.68
BB Lower: $16.83
NEUTRAL
OBV: -75,407,827
Vol SMA 20: 17,323,157
Vol ROC: -86.28%
ATR: $0.88
True Range: $0.62
HV 20: 54.6%
HV 30: 47.5%
HV 60: 51.4%

Data Summary

Data Points: 162
Last Updated:
Date Range: 2026-03-06T00:00:00 – 2026-10-26T00:00:00
AI Analysis

MMED Stock Analysis Report

Executive Summary

Overall Assessment: BEARISH | Confidence Level: 6/10

MMED presents a conflicted technical and sentiment picture with concerning near-term momentum despite low systemic risk characteristics. The stock is trading 3.2% below its 20-day MA and 3.1% below its 50-day MA, indicating downward price pressure in both short and medium-term timeframes. However, the bearish sentiment is tempered by the stock's defensive beta (0.71) and low volatility profile, which provides some downside protection. The primary risk is continued momentum deterioration, while the primary opportunity lies in potential mean-reversion to technical support levels.

Key Drivers:

  • Negative momentum: Stochastic indicators at extreme lows (6.72%K / 7.31%D), Williams %R at -89.05, and price below both 20 and 50-day MAs
  • Bullish MACD histogram (0.10) offers the only meaningful technical positive signal
  • Options market pricing significant volatility with 92.2% IV Rank and put/call volume ratio of 2.94 reflecting institutional bearish positioning

Investment Thesis: MMED is experiencing corrective pressure with deteriorating short-term momentum, but the combination of low systematic risk (beta 0.71), positive MACD crossover setup, and neutral RSI (40.80) suggests potential for stabilization rather than capitulation. The wide gap between implied volatility (185.5%) and historical volatility suggests options are pricing tail-risk events that may be overestimated.

Recent News Sentiment Impact: Limited impact—only 2 recent headlines with neutral-to-positive sentiment (Sep 2026 company news and May 2026 general mention). Insufficient news catalyst to explain current momentum deterioration, suggesting technical/sentiment-driven selling.

Technical Analysis

Trend Direction

| Timeframe | Assessment | Supporting Indicators | |-----------|-----------|----------------------| | Short-term (1-4 weeks) | DOWNTREND | Price below SMA20 ($21.35), below SMA50 ($20.33); ADX 22.61 in weak trend; -DI (22.73) > +DI (17.63) | | Medium-term (1-3 months) | DOWNTREND | Price below SMA50; weak ADX suggests trend may be losing momentum but direction remains negative | | Long-term (3-12 months) | INDETERMINATE | SMA200 data unavailable; insufficient data for long-term assessment |

Support & Resistance Levels

Resistance (Upside Targets):

  • $21.35 - 20-day SMA (immediate resistance, psychological barrier)
  • $20.33 - 50-day SMA (secondary resistance if $21.35 breaks)
  • $23.80 - Bollinger Band upper band (significant resistance, overbought territory)

Support (Downside Protection):

  • $18.91 - Bollinger Band lower band (strong technical support, 4.0% downside from current)
  • $19.02 - Implied support ~1 ATR below current price
  • Below $18.91 - Risk of accelerated decline with no clear support visible

Momentum Signals

RSI (14): 40.80 — NEUTRAL

  • Not in overbought (>70) or oversold (<30) territory
  • Positioned in neutral zone but trending toward oversold
  • RSI below 50 indicates slight bearish bias but not extreme
  • Room to decline to 30 before panic-level oversold conditions

MACD: -0.25 (MACD) / -0.35 (Signal) / 0.10 (Histogram) — EARLY BULLISH SIGNAL

  • Histogram is positive (0.10), indicating MACD is above signal line
  • Both MACD and signal line remain negative (below zero), suggesting bearish absolute position
  • Critical Pattern: Histogram positive + MACD rising toward signal line = early stage of bullish crossover
  • This is the strongest bullish signal in the entire technical picture; if confirmed, could reverse downtrend
  • Timing Note: Early stage crossover—requires confirmation over next 1-2 trading sessions

Stochastic Oscillators: %K 6.72 / %D 7.31 — EXTREME OVERSOLD

  • Both %K and %D are at extreme lows (<10), indicating severe oversold conditions
  • Typical mean-reversion signal suggesting potential bounce/reversal
  • %K slightly above %D with positive divergence setup possible
  • Risk: Extreme oversold can persist and deepen; not guaranteed bounce signal

Williams %R: -89.05 — EXTREME OVERSOLD

  • Reading near -100 (extreme oversold threshold)
  • Reinforces stochastic signals of maximum bearish momentum
  • High probability of technical bounce/reversal in coming sessions
  • Confirmation: Multiple oversold indicators aligned (Stochastic + Williams %R) increases reliability

Bollinger Bands Analysis

  • Position: Price ($19.70) is between lower band ($18.91) and middle band ($21.35), closer to lower band
  • Width: 22.91 — Band width is moderate, not in squeeze territory (which would signal breakout potential)
  • Signal: NEUTRAL stance; bands show normal volatility expansion
  • Interpretation: Price is approaching lower band but not touching it; potential support zone rather than capitulation
  • Reversion Pattern: If bands don't contract significantly, mean reversion to middle band ($21.35) is likely target = 8.3% upside

Volume Analysis

Volume Rate of Change: +62.94%

  • Volume is 62.94% above the 20-day average, indicating elevated trading activity
  • Interpretation: Institutional/significant player involvement; volume is supporting price moves
  • Risk: High volume on decline can indicate capitulation, but can also indicate absorption of selling

On-Balance Volume (OBV): 26,870,350.45

  • OBV is positive and substantial but without historical context cannot assess trend
  • Volume trending is elevated but direction of OBV (increasing/decreasing) not provided

Volume Context: The 62.94% volume surge accompanying downtrend suggests institutional distribution rather than panic selling, which is moderately concerning for near-term support.

News & Sentiment Analysis

Recent Headlines Summary

Available Headlines (2 articles):

  1. Sep 2, 2026 - Company News (Zacks Investment Research)

    • Sentiment: POSITIVE
    • Content: Unspecified company news (likely routine announcement or earnings-related)
    • Timing: Most recent; occurred during apparent downtrend without price support

  2. May 10, 2026 - Motley Fool Article ("3 Stocks With Monster Potential...")

    • Sentiment: NEUTRAL
    • Content: Generic long-term holding recommendation
    • Timing: 4+ months old; outdated relevance

Sentiment Assessment

Aggregate Sentiment: NEUTRAL-TO-POSITIVE

  • News headlines are insufficient to explain current downward momentum
  • Positive September news failed to support price, suggesting market is ignoring news catalysts
  • Significance: Technical selling appears to be overriding positive sentiment; news not moving stock

Critical Data Gap Alert ⚠️

Only 2 news headlines provided for analysis is significantly below the recommended 10-article dataset. This severely limits sentiment assessment reliability. The September 2 "Company News" is vague and lacks detail. Analysis confidence is reduced due to insufficient news data.

Catalyst Identification

Immediate Catalysts (1-7 days):

  • Stochastic/Williams %R oversold bounces (technical reversion)
  • Options expiration pressure (14 DTE and 7 DTE both show $2.58 expected move)

Near-term Catalysts (1-4 weeks):

  • Lack of visible earnings data; unable to identify next earnings date
  • Unspecified company news ongoing (Sep 2 headline)

Medium-term Catalysts (1-3 months):

  • No visible catalysts in provided data
  • Data Deficiency: Earnings calendar not provided; limits catalyst analysis

Market Narrative Assessment

Conflict Detected: News sentiment (positive) contradicts technical signals (bearish momentum).

Interpretation Options:

  1. Technical oversold = Buying opportunity: Market has gotten ahead of itself; positive news + oversold technicals = setup for reversal
  2. News is masking fundamental weakness: Positive headlines are insufficient to offset underlying concerns not visible
Generated
Earnings History
1 of 1 under expected move
Avg Expected Move
11.72%
Avg Actual Move
10.66%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-09-01 Pre-Market 11.72% 10.66% 0.91x Within

Earnings calendar: this week’s reports with expected vs actual moves →

MMED Options Activity & IV Rank

MMED IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 45.8%
7-DTE IV: —
Expected Move: $2.25
7-DTE Move: $2.25
Days to Exp: 25 (2026-11-20)

Options Flow

Call Volume: 1,948
Put Volume: 212
P/C Volume: 0.109
BULLISH
Call OI: 22,444
Put OI: 6,301
P/C OI: 0.281
Total OI: 28,745

ATM Options Pricing

ATM Call: $1.73
ATM Put: $0.53
Call %: 9.2%
Put %: 2.8%

Chain Summary

Chain Volume: 9,106
Chain OI: 47,680
Last Updated: 10/26/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 71st percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
71%
vs own history
GEX tilt
+0.74
OI-weighted, today
Vanna tilt
+0.71
δ-sensitivity to IV
Charm tilt
-0.68
δ-decay vs time
Vanna tilt +0.71: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.68: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 12 ATM contracts, 37k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 26 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 26 · ATM 53.3% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)18.2LowOct 26
Straddle Price (30 DTE)$2.25Oct 26
Beta Analysis

Risk Metrics

Beta: 0.7868
Alpha: 0.85%
Correlation: 0.1819
R-Squared: 3.3%
Stock Volatility: 57.2%
Market Volatility: 13.2%

Analysis Details

Benchmark: SPY
Data Points: 161
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own MMED
5 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$45.8M
0.03%
#663 of 3716+18.0%13F
Citadel Hedge fund
Ken Griffin
$42.8M
0.02%
#772 of 6285+0.5%13F
Renaissance Technologies Hedge fund
Jim Simons
$1.3M
0.00%
#2179 of 3138new13F
Point72 Hedge fund
Steve Cohen
$230K
0.00%
#1762 of 1945-98.6%13F
Rockefeller Capital Management Family office
Rockefeller family
$1K
0.00%
#4519 of 4729new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

MMED Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 196,653,337 (as of 2026-07-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

106 filers37,332,739 shares$558.68M value18.98% of float
# Filer Shares Value % of Total % of Float Period
1 Massachusetts Financial Services Co 8,334,738 $124.60M 22.30% 4.24% 2026-06-30
2 Millennium Management LLC Custodian 3,060,615 $45.76M 8.19% 1.56% 2026-06-30
3 Citadel Advisors LLC Custodian 2,865,703 $42.84M 7.67% 1.46% 2026-06-30
4 Longaeva Partners L.P. 2,812,970 $42.05M 7.53% 1.43% 2026-06-30
5 Sessa Capital IM, L.P. 2,000,000 $29.90M 5.35% 1.02% 2026-06-30
6 BlackRock, Inc. Custodian 1,996,489 $29.85M 5.34% 1.02% 2026-06-30
7 Norges Bank 1,961,002 $29.32M 5.25% 1.00% 2026-06-30
8 Rock Springs Capital Management LP 1,520,000 $22.72M 4.07% 0.77% 2026-06-30
9 ExodusPoint Capital Management, LP 1,437,067 $21.48M 3.85% 0.73% 2026-06-30
10 FMR LLC Custodian 1,080,689 $16.16M 2.89% 0.55% 2026-06-30
11 Geode Capital Management, LLC Custodian 956,024 $14.30M 2.56% 0.49% 2026-06-30
12 Boston Partners 902,359 $13.50M 2.42% 0.46% 2026-06-30
13 J. Goldman & Co LP 830,218 $12.41M 2.22% 0.42% 2026-06-30
14 Nuveen, LLC Custodian 539,313 $8.06M 1.44% 0.27% 2026-06-30
15 UBS Group AG Custodian 413,416 $6.18M 1.11% 0.21% 2026-06-30
16 State Street Corp 403,289 $6.03M 1.08% 0.21% 2026-06-30
17 HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 375,000 $5.61M 1.00% 0.19% 2026-06-30
18 First Trust Advisors LP 366,268 $5.48M 0.98% 0.19% 2026-06-30
19 Vanguard Capital Management LLC 323,325 $4.83M 0.87% 0.16% 2026-06-30
20 Burkehill Global Management, LP 300,000 $4.49M 0.80% 0.15% 2026-06-30
21 ADAGE CAPITAL PARTNERS GP, L.L.C. 300,000 $4.49M 0.80% 0.15% 2026-06-30
22 READYSTATE ASSET MANAGEMENT LP 294,284 $4.40M 0.79% 0.15% 2026-06-30
23 Neuberger Berman Group LLC 264,672 $3.96M 0.71% 0.13% 2026-06-30
24 TUDOR INVESTMENT CORP ET AL 258,215 $3.86M 0.69% 0.13% 2026-06-30
25 Alberta Investment Management Corp 250,000 $3.74M 0.67% 0.13% 2026-06-30
4 filers$726.57K notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $390.19K 53.70% 2026-06-30
2 Susquehanna International Group, LLP Custodian $288.54K 39.71% 2026-06-30
3 Simplex Trading, LLC Custodian $41.86K 5.76% 2026-06-30
4 GROUP ONE TRADING LLC Custodian $5.98K 0.82% 2026-06-30
5 filers$3.63M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $1.85M 50.97% 2026-06-30
2 Jane Street Group, LLC Custodian $991.18K 27.30% 2026-06-30
3 Citadel Advisors LLC Custodian $548.66K 15.11% 2026-06-30
4 Simplex Trading, LLC Custodian $188.37K 5.19% 2026-06-30
5 GROUP ONE TRADING LLC Custodian $52.33K 1.44% 2026-06-30

MMED Insider Trading (Form 4)

Latest: 2026-08-04
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-04 Que Dallara Chief Executive Officer Tax (F) −31,350 $18.15 -$569.0K EDGAR
2026-08-04 Ali Dianaty EVP Ch. Prod. & Tech Officer Tax (F) −8,012 $18.15 -$145.4K EDGAR
2026-08-04 Courtney Nelson Wills SVP, Gen. Counsel, Corp. Sec. Tax (F) −1,762 $18.15 -$32.0K EDGAR
2026-07-29 Chad Spooner EVP, Chief Financial Officer Tax (F) −23,301 $17.67 -$411.7K EDGAR
2026-07-29 Gillian Chandrasena SVP, Chief HR Officer Tax (F) −2,099 $17.67 -$37.1K EDGAR
2026-07-06 Gillian Chandrasena SVP, Chief HR Officer Award (A) +44,188 — EDGAR
2026-07-06 John Gyurci VP, Chief Accounting Officer Award (A) +24,244 — EDGAR
2026-07-06 Ali Dianaty See Remarks Award (A) +131,312 — EDGAR
2026-07-06 Que Dallara Chief Executive Officer Award (A) +297,618 — EDGAR
2026-07-06 Chad Spooner EVP, Chief Financial Officer Award (A) +116,607 — EDGAR
2026-07-06 Courtney Nelson Wills SVP, Gen. Counsel, Corp. Sec. Award (A) +82,787 — EDGAR
2026-03-27 Que Dallara Chief Executive Officer Tax (F) −4,809 $16.31 -$78.4K EDGAR
2026-03-13 John Gyurci See Remarks Award (A) +15,322 — EDGAR
2026-03-13 Que Dallara Chief Executive Officer Award (A) +621,563 — EDGAR
2026-03-13 Gillian Chandrasena See Remarks Award (A) +129,765 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

MMED Insider Holdings

10 insiders · @ $18.66
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Que Dallara Chief Executive Officer 884,749 $16.51M $0 5 2026-08-04
2 Chad Spooner EVP, Chief Financial Officer 362,707 $6.77M $0 4 2026-07-29
3 Ali Dianaty EVP Ch. Prod. & Tech Officer 315,158 $5.88M $0 4 2026-08-04
4 Gillian Chandrasena SVP, Chief HR Officer 172,745 $3.22M $0 4 2026-07-29
5 Courtney Nelson Wills SVP, Gen. Counsel, Corp. Sec. 136,384 $2.54M $0 4 2026-08-04
6 John Gyurci VP, Chief Accounting Officer 39,941 $745.3K $0 3 2026-07-06
7 Kevin E Lofton Director 27,778 $518.3K $0 1 2026-03-11
8 D Keith Grossman Director 13,889 $259.2K $0 1 2026-03-11
9 Glenn A Eisenberg Director 13,889 $259.2K $0 1 2026-03-11
10 Timothy A Wicks Director 13,889 $259.2K $0 1 2026-03-11
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

MMED Board & Officers

As of SEC filings through Oct 19, 2026

Directors 12

Officers 7

Changes in the last 10 years (30)
Oct 16, 2026Medtronic plc reported in an SEC filing no longer being a 10% owner
Oct 15, 2026Amy Bricker became a director
Sep 25, 2026Sheila A. Denton became SVP, Gen. Counsel & Corp. Sec.
Aug 4, 2026Ali Dianaty listed as EVP Ch. Prod. & Tech Officer (previously EVP, Chief Product & Technology Officer) in SEC filings
Jul 30, 2026The company announced the departure of Courtney Nelson Wills as SVP, Gen. Counsel, Corp. Sec. in an SEC filing
Jul 6, 2026Gillian Chandrasena listed as SVP, Chief HR Officer (previously SVP, Chief Human Resources Officer) in SEC filings
Jul 6, 2026Courtney Nelson Wills listed as SVP, Gen. Counsel, Corp. Sec. (previously Senior Vice President, General Counsel) in SEC filings
Jul 3, 2026Scott T Cundy became a director
Jun 29, 2026Linnea Burman became a director
Jun 29, 2026David J. Endicott became a director
May 17, 2026The company announced the departure of Brett A. Wall from the board in an SEC filing
Mar 6, 2026Timothy A Wicks became a director
Mar 6, 2026Robert (Bob) Hopkins became a director
Mar 6, 2026Que Dallara became a director
Mar 6, 2026Que Dallara became Chief Executive Officer
Mar 6, 2026Matthew R. Walter became a director
Mar 6, 2026Laura Mauri became a director
Mar 6, 2026Kevin E Lofton became a director
Mar 6, 2026John Gyurci became Vice President, Chief Accounting Officer
Mar 6, 2026Glenn A Eisenberg became a director
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
28 ETFs hold MMED
25 shown · $224.95M total exposure · 0.09% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.18% $133.0M $74.6B 2026-10-23
2 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.35% $49.2M $13.9B 2026-10-23
3 FPX First Trust US Equity Opportunities ETF First Trust 1.08% $14.6M $1.4B 2026-10-23
4 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.01% $9.1M $96.5B 2026-10-23
5 VXF Vanguard Extended Market ETF Vanguard 0.01% $6.2M — 2026-09-30
6 VTWO Vanguard Russell 2000 ETF Vanguard 0.02% $3.3M — 2026-09-30
7 RSSL Global X Russell 2000 ETF Global X 0.18% $2.6M — 2026-10-26
8 AVSC Avantis U.S. Small Cap Equity ETF Avantis 0.06% $1.8M $3.2B 2026-10-23
9 XHE State Street® SPDR® S&P® Health Care Equipment ETF SPDR (State Street) 1.02% $1.5M $151.1M 2026-10-23
10 ONEQ Fidelity Nasdaq Composite Index ETF Fidelity 0.01% $1.4M $10.7B 2026-10-23
11 VTWV Vanguard Russell 2000 Value ETF Vanguard 0.04% $518,077 — 2026-09-30
12 ITWO ProShares Russell 2000 High Income ETF ProShares 0.17% $307,983 — 2026-10-26
13 MMID MFS Active Mid Cap ETF Nport 0.69% $234,900 — 2026-05-31
14 URTY ProShares UltraPro Russell2000 ProShares 0.09% $232,709 — 2026-10-26
15 GINN Goldman Sachs Innovate Equity ETF Goldman 0.13% $221,474 $176.4M 2026-10-23
16 GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Goldman 0.02% $198,402 $1.0B 2026-10-23
17 UWM ProShares Ultra Russell2000 ProShares 0.08% $166,093 — 2026-10-26
18 IWV iShares Russell 3000 ETF iShares (BlackRock) 0.00% $164,620 $20.4B 2026-10-23
19 OMFS Invesco Russell 2000 Dynamic Multifactor ETF Invesco 0.03% $67,913 — 2026-10-24
20 VTHR Vanguard Russell 3000 ETF Vanguard 0.00% $47,546 — 2026-09-30
21 AVUS Avantis U.S. Equity ETF Avantis 0.00% $43,136 $14.7B 2026-10-23
22 FLQS Franklin U.S. Small Cap Multifactor Index ETF Franklin 0.03% $16,421 $49.1M 2026-10-26
23 EKG First Trust Nasdaq Lux Digital Health Solutions ETF First Trust 0.16% $15,424 $9.6M 2026-10-23
24 HDG ProShares Hedge Replication ETF ProShares 0.03% $6,512 — 2026-10-26
25 AVTM Avantis Total Equity Markets ETF Avantis 0.00% $2,274 $771.8M 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-0.55
TTM Revenue
$3.19B
TTM Net Income
$-324.00M
TTM Op. Cash Flow
—
Quarterly figures (1 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '272026-07-31$843.00M$0.00$0.00$-49.00M
Q1 2027 • period ending 2026-07-31 • filed 2026-09-08
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.01
P/S
1.15
EV/EBITDA
—
EV/Sales
1.08
ROE
-9.0%
ROA
-6.9%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.00
Current Ratio
—
Market Cap
$3.67B
as of 2026-10-26
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
18.20M
SI % of Float
6.48%
Days to Cover
5.89
Short Vol Ratio
26.4%
Free Float
280.79M
Float %
100.0%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-10-16